gentamicin has been researched along with Temporomandibular Joint Disorders in 2 studies
Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.
Temporomandibular Joint Disorders: A variety of conditions affecting the anatomic and functional characteristics of the temporomandibular joint. Factors contributing to the complexity of temporomandibular diseases are its relation to dentition and mastication and the symptomatic effects in other areas which account for referred pain to the joint and the difficulties in applying traditional diagnostic procedures to temporomandibular joint pathology where tissue is rarely obtained and x-rays are often inadequate or nonspecific. Common diseases are developmental abnormalities, trauma, subluxation, luxation, arthritis, and neoplasia. (From Thoma's Oral Pathology, 6th ed, pp577-600)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Osteomyelitis is an extremely unusual complication of invasive otitis externa." | 1.33 | [Temporomandibular osteomyelitis secondary to progressive necrotizing otitis externa]. ( Boulaïch, M; Filali, A; Jamal, H; Kzadri, M; Lazrak, A; Nazih, N; Oujilal, A, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nazih, N | 1 |
| Filali, A | 1 |
| Boulaïch, M | 1 |
| Jamal, H | 1 |
| Oujilal, A | 1 |
| Lazrak, A | 1 |
| Kzadri, M | 1 |
| Henney, JE | 1 |
2 other studies available for gentamicin and Temporomandibular Joint Disorders
| Article | Year |
|---|---|
[Temporomandibular osteomyelitis secondary to progressive necrotizing otitis externa].
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Gentamicins; Humans; Male; Necrosis; Osteomyelitis; Otit | 2006 |
From the Food and Drug Administration.
Topics: Diabetes Mellitus, Type 2; Endotoxemia; Gentamicins; Humans; Hypoglycemic Agents; Joint Prosthesis; | 1999 |